Summit Therapeutics Inc. (SMMT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | -100% | -100% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | -100% | -100% |
| Operating Expenses | 195.21M | 224.88M | 234.21M | 414.14M | 51.75M | 52.41M | 43.66M | 47.16M | 33.59M | 28.4M | 16.8M | 12.44M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 62.59M | 77.58M | 103.11M | 262.58M | 12.06M | 11.53M | 15.25M | 10.93M | 9.13M | 9.08M | 4.45M | 4.97M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 132.62M | 147.29M | 131.1M | 151.56M | 39.68M | 41.04M | 28.22M | 36.23M | 24.47M | 19.46M | 12.56M | 7.44M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -163.74K | 197.46K | 0 | 0 | -140.41K | -217.21K | 21.26K |
| Operating Income | -195.21M | -224.88M | -234.21M | -414.14M | -51.75M | -52.41M | -43.66M | -47.16M | -33.59M | -28.4M | -16.8M | -12.44M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -277.24% | -329.08% | -436.4% | -778.13% | -54.05% | -84.51% | -159.96% | -279.21% | 92.28% | -69.16% | -10.72% | -19.28% |
| EBITDA | -195.17M | -224.83M | -234.17M | -414.11M | -51.73M | -52.39M | -43.65M | -47.15M | -33.57M | -28.38M | -16.77M | -12.4M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -277.3% | -329.14% | -436.48% | -778.37% | -54.09% | -84.6% | -160.28% | -280.19% | 92.29% | -71.59% | -12.61% | -22.12% |
| D&A (Non-Cash Add-back) | 44K | 42K | 42K | 27K | 19.35K | 17.57K | 14.96K | 15.82K | 21.4K | 23.53K | 26.23K | 36.22K |
| EBIT | -195.21M | -219.12M | -231.79M | -414.14M | -51.75M | -52.41M | -43.66M | -35.29M | -33.59M | -28.4M | -16.8M | -12.44M |
| Net Interest Income | 0 | 0 | 0 | 2.98M | 0 | 13.46M | -2.46M | -3.1M | -3.12M | -522K | -237K | 771K |
| Interest Income | 0 | 0 | 0 | 2.98M | 0 | 13.47M | 0 | 0 | 0 | 2.38M | 2.48M | 3.29M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 9K | 2.46M | 3.1M | 3.12M | 2.9M | 2.72M | 2.52M |
| Other Income/Expense | 5.79M | 5.75M | 2.42M | 1.99M | 3.05M | 3.52M | 1.59M | -607.54K | -859.04K | -280.04K | -636.06K | 848.06K |
| Pretax Income | -189.42M | -219.12M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -189.42M | -219.17M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -288.97% | -348.34% | -450.9% | -762.81% | -41.36% | -70.43% | -141.36% | -312.2% | 92.16% | -80.33% | 8.97% | 15.89% |
| Net Income (Continuing) | -189.42M | -219.12M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.24 | -0.29 | -0.31 | -0.56 | -0.07 | -0.07 | -0.06 | -0.07 | -0.05 | -0.04 | -0.03 | -0.02 |
| EPS Growth % | -244.33% | -305.03% | -418.39% | -686.52% | -41.96% | -75.06% | -139.2% | -328.92% | 95.77% | 31.14% | 80.77% | 88.14% |
| EPS (Basic) | -0.24 | -0.29 | -0.31 | -0.56 | -0.07 | -0.07 | -0.06 | -0.07 | -0.05 | -0.04 | -0.03 | -0.02 |
| Diluted Shares Outstanding | 775.46M | 766.4M | 743.42M | 742.62M | 738.08M | 737.5M | 726.66M | 707.9M | 701.78M | 700.6M | 697.74M | 697.68M |
| Basic Shares Outstanding | 775.46M | 766.4M | 743.42M | 742.61M | 699.04M | 683.17M | 703.17M | 670.94M | 701.79M | 700.61M | 697.75M | 697.69M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |